Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause Product administration error? 71 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Product administration error have been filed in association with TREPROSTINIL (TYVASO). This represents 0.1% of all adverse event reports for TREPROSTINIL.

71
Reports of Product administration error with TREPROSTINIL
0.1%
of all TREPROSTINIL reports
4
Deaths
31
Hospitalizations

How Dangerous Is Product administration error From TREPROSTINIL?

Of the 71 reports, 4 (5.6%) resulted in death, 31 (43.7%) required hospitalization, and 3 (4.2%) were considered life-threatening.

Is Product administration error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 71 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause Product administration error?

HYDROXYPROGESTERONE CAPROATE (972) ACETAMINOPHEN (666) CENEGERMIN-BKBJ (613) LEUPROLIDE (595) EVOLOCUMAB (565) ADALIMUMAB (543) METHYLPHENIDATE (414) OLMESARTAN MEDOXOMIL (314) ASPIRIN (241) SECUKINUMAB (225)

Which TREPROSTINIL Alternatives Have Lower Product administration error Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All Product administration error Reports All Drugs Causing Product administration error TREPROSTINIL Demographics